Susanne Wagner
Advisory Board
Topas Therapeutics
Germany
Biography
Susanne Wagner has more than 25 years in nanodrug research and development. Starting at the Dept. of Contrast Media Research at Schering AG in cooperation with the Institute für Diagnostikforschung GmbH Berlin she participated in the development of Resovist® and liposomal encapsulated iodinated contrast media with responsibilites in the area of in-vivo imaging and safety pharmacology. Later on as a Co-Founder of Ferropharm GmbH she successfully managed the whole line of development up to clinical trials phase II of an iron oxide based contrast medium. With this background she has a unique expertise in preclinical and clinical development of iron oxide based nanodrugs including aspects of physics, chemistry and non-clinical testing with special focus on regulatory requirements.
Research Interest
Pharmacology
